News
1h
WNEM on MSNA New Therapy for Melanoma: When All Else FailsThe FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.
15hon MSN
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, ...
Chinese women aged 65 years or older have significantly higher rates of high-risk human papillomavirus infection and cervical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results